Search Results - "Boss, Carol"

Alemtuzumab Treatment of Intermediate-1 Myelodysplasia Patients Is Associated With Sustained Improvement in Blood Counts and Cytogenetic Remissions by SLOAND, Elaine M, OLNES, Matthew J, YOUNG, Neal S, SHENOY, Aarthie, WEINSTEIN, Barbara, BOSS, Carol, LOELIGER, Kelsey, WU, Colin O, MORE, Kenneth, BARRETT, A. John, SCHEINBERG, Phillip

“…Myelodysplastic syndromes (MDS) are characterized by ineffective hematopoiesis and progression to leukemia. Clinical and experimental evidence suggests an…”
Get full text

Treatment of severe aplastic anemia with a combination of horse antithymocyte globulin and cyclosporine, with or without sirolimus: a prospective randomized study by Scheinberg, Phillip, Wu, Colin O, Nunez, Olga, Scheinberg, Priscila, Boss, Carol, Sloand, Elaine M, Young, Neal S

“…1 Hematology Branch and 2 Office of Biostatistics Research, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA…”
Get full text

Repeated PR1 and WT1 peptide vaccination in Montanide-adjuvant fails to induce sustained high-avidity, epitope-specific CD8+ T cells in myeloid malignancies by REZVANI, Katayoun, YONG, Agnes S. M, BARRETT, A. John, MIELKE, Stephan, JAFARPOUR, Behnam, SAVANI, Bipin N, LE, Robert Q, ENIAFE, Rhoda, MUSSE, Laura, BOSS, Carol, KURLANDER, Roger

“…We previously showed that vaccination with one dose of PR1 and WT1 peptides induces transient anti-leukemia immunity. We hypothesized that maintenance of a…”
Get full text

Lenalidomide-induced upregulation of CD80 on tumor cells correlates with T-cell activation, the rapid onset of a cytokine release syndrome and leukemic cell clearance in chronic lymphocytic leukemia by Aue, Georg, Njuguna, Ndegwa, Tian, Xin, Soto, Susan, Hughes, Thomas, Vire, Berengere, Keyvanfar, Keyvan, Gibellini, Federica, Valdez, Janet, Boss, Carol, Samsel, Leigh, McCoy, J. Philip, Jr, Wilson, Wyndham H, Pittaluga, Stefania, Wiestner, Adrian

“…1 Hematology Branch, NHLBI 2 Office of Biostatistics Research, NHLBI 3 Department of Pharmacy, Clinical Center 4 Flow Cytometry Core Facility, NHLBI 5…”
Get full text

Anti-interleukin-2 receptor antibody (daclizumab) treatment of corticosteroid-refractory autoimmune thrombocytopenic purpura by Fogarty, PF, Seggewiss, R, McCloskey, DJ, Boss, CA, Dunbar, CE, Rick, ME

“…We administered daclizumab, a humanized monoclonal anti-interleukin-2 receptor (IL-2R) antibody, to 11 patients with corticosteroid-refractory autoimmune…”
Get full text

Concurrent Paclitaxel and Radiation in the Treatment of Locally Advanced Head and Neck Cancer by SUNWOO, John B, HERSCHER, Laurie L, RUDY, Susan, MUIR, Chris, SUOPING ZHAI, FIGG, William D, COOK, John A, MITCHELL, James B, VAN WAES, Carter, KROOG, Glenn S, THOMAS, Giovana R, ONDREY, Frank G, DUFFEY, Dianne C, SOLOMON, Beth I, BOSS, Carol, ALBERT, Paul S, MCCULLUGH, Linda

“…To determine the feasibility of an organ preservation regimen consisting of infusional paclitaxel administered concurrently with radiotherapy to patients with…”
Get full text

Leukemia-associated antigen-specific T-cell responses following combined PR1 and WT1 peptide vaccination in patients with myeloid malignancies by Rezvani, Katayoun, Yong, Agnes S.M., Mielke, Stephan, Savani, Bipin N., Musse, Laura, Superata, Jeanine, Jafarpour, Behnam, Boss, Carol, Barrett, A. John

“…We describe the safety and immunogenicity of a combined vaccine of 2 leukemia-associated antigenic peptides, PR1 and WT1. Eight patients with myeloid…”
Get full text

A pilot study evaluating the safety and CD34+ cell mobilizing activity of escalating doses of plerixafor in healthy volunteers by Lemery, Steven J., Hsieh, Matthew M., Smith, Aleah, Rao, Sheila, Khuu, Hanh M., Theresa, Donohue, Viano, Jennifer M., Cook, Lisa, Goodwin, Rose, Boss, Carol, Calandra, Gary, Geller, Nancy, Tisdale, John, Childs, Richard

“…Summary This study evaluated the safety and CD34+ cell mobilizing activity of escalating doses of plerixafor in healthy volunteers. Three cohorts of six…”
Get full text

The Response to Repeated Vaccination with PR1 and WT1 Peptides Admixed in Montanide Adjuvant Is Transient and Fails to Induce Sustained Anti-Leukemia Responses in Patients with Myeloid Malignancies by Rezvani, Katayoun, Yong, Agnes S.M., Mielke, Stephan, Jafarpour, Behnam, Savani, Bipin N., Le, Quan, Eniafe, Rhoda, Boss, Carol, Kurlander, Roger J, Barrett, A. John

“…Abstract 4096 Poster Board III-1031 We previously demonstrated the immunogenicity of a combined vaccine approach employing two leukemia-associated antigenic…”
Get full text

Recombinant humanized anti-IL-2 receptor antibody (daclizumab) produces responses in patients with moderate aplastic anemia by Maciejewski, Jaroslaw P., Sloand, Elaine M., Nunez, Olga, Boss, Carol, Young, Neal S.

“…In contrast to severe aplastic anemia (sAA), the appropriate management of patients with moderate pancytopenia is unclear. In this study, we examined the…”
Get full text

Allografts Selectively Photodepleted of GvHD Causing T Cells and Followed by Low-Level Immunosuppression: A Novel Method to Improve Disease Control After HLA-Matched Sibling Transplantations by Mielke, Stephan, Shenoy, Aarthi, Rezvani, Katayoun, Yong, Agnes S.M., McIver, Zachariah A., Fellowes, Vicki S., Savani, Bipin N., Kurlander, Roger, Khuu, Hanh, Boss, Carol, Barrett, A.John

“…Abstract 515 We established a highly efficient GMP-grade, ex-vivo selective allodepletion process where host-activated donor T cells are eliminated based on…”
Get full text

Selective Allodepletion by TH9402-Mediated Photosensitization Results in Early Full Donor T Cell Reconstitution in the Absence of High-Grade, Acute GvHD and Is Associated with Favorable Outcome after HLA Matched Sibling SCT for Hematologic Malignancies by Mielke, Stephan, Shenoy, Aarthi, Fellowes, Vicki S., Rezvani, Katayoun, Savani, Bipin N., Musse, Laura, Wisch, Laura, Kurlander, Roger, Khuu, Hanh, Boss, Carol, Barrett, A. John

“…Selective allodepletion (SD) is a strategy to eliminate host-reactive donor T-cells from allografts to prevent graft versus host disease (GvHD) while…”
Get full text

Leukemia-Associated Antigen Specific T-Cell Responses Following Combined PR1 and WT1 Peptide Vaccination in Patients with Myeloid Malignancies by Rezvani, Katayoun, Yong, Agnes S.M., Mielke, Stephan, Savani, Bipin N., Musse, Laura, Superata, Jeanine, Jafarpour, Behnam, Boss, Carol, Barrett, A. John

“…The graft-versus-leukemia (GVL) effect following allogeneic stem cell transplantation (SCT) is evidence that T lymphocytes can eradicate leukemia. The…”
Get full text

A Pilot Study Evaluating the CD34+ Cell Mobilizing Activity and Adverse Events Associated with Escalating Doses of AMD3100 in Healthy Volunteers by Lemery, Steven J., Hsieh, Matthew M., Smith, Aleah, Rao, Sheila, Khuu, Hanh M., Theresa, Donohue, Karpovich, Jennifer M., Cook, Lisa, Goodwin, Rose, Boss, Carol, Calandra, Gary, Geller, Nancy, Tisdale, John, Childs, Richard

“…Background: AMD3100 (AMD or plerixafor) inhibits the binding of SDF-1 to its cognate receptor CXCR4 resulting in the rapid mobilization of CD34+ hematopoietic…”
Get full text

Immunosuppression for Myelodysplastic Syndrome: Association between a Score Based on Presenting Features and Long-Term Survival by Sloand, Elaine M., Saunthrararajah, Yogan, Battiwalla, Minoo, Nakamura, Ryo, Boss, Carol, Aliyu, Zakari Y., Young, Neal S., Barrett, John

“…Immunosuppressive therapy (IST) can improve cytopenias in selected patients with myelodysplastic syndrome (MDS). Between 1998 and 2004, 133 patients with MDS…”
Get full text

Improved Outcome for Peripheral Blood Stem Cell Transplantation for Advanced Primary Myelodysplastic Syndrome by Solomon, Scott R., Savani, Bipin N., Childs, Richard, Montero, Aldemar, Boss, Carol, Read, Elizabeth J., Leitman, Susan F., Barrett, A. John

“…Stem cell transplantation for myelodysplastic syndrome (MDS) is characterized by high transplant-related mortality (TRM), especially in older patients and…”
Get full text

Clinical and immunologic assessment of patients with psoriasis in a randomized, double-blind, placebo-controlled trial using recombinant human interleukin 10 by Kimball, Alexa B, Kawamura, Tatsuyoshi, Tejura, Krupali, Boss, Carol, Hancox, Ana R, Vogel, Jonathan C, Steinberg, Seth M, Turner, Maria L, Blauvelt, Andrew

“…In several open-label studies, recombinant human interleukin 10 (rhIL-10), a type 2 anti-inflammatory cytokine, has been reported to improve psoriasis, a…”
Get more information

The immobilization and clinical evaluation of enzymes on nylon tubing modified with long spacer arms peroxidase, glucose oxidase and oxalate oxidase by Boss, Sheila Carol

Get full text

The development of an automated technique for the determination of lecithin a study of lecithin levels in serum of normal subjects and patients under cardiac care by Boss, Sheila Carol

Get full text